Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shany Koren

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Molecular Cell|November 23, 2015
Breast Tumor Heterogeneity: Source of Fitness, Hurdle for TherapyShany Koren, Mohamed Bentires-Alj
The FEBS Journal|February 7, 2013
Mouse models of PIK3CA mutations: one mutation initiates heterogeneous mammary tumorsShany Koren, Mohamed Bentires-Alj
Cancer Cell|May 10, 2017
Tackling Resistance to PI3K Inhibition by Targeting the EpigenomeShany Koren, Mohamed Bentires-Alj
Nature Reviews. Genetics|November 21, 2023
Interrogating epigenetic mechanisms with chemically customized chromatinNir Hananya, Shany Koren, Tom W Muir
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2023
A genetically encoded photoproximity labeling approach for mapping protein territoriesNir Hananya, Xuanjia Ye, Shany Koren, et al.
Endocrinology|March 24, 2011
Genetic ablation of sfrp4 in mice does not affect serum phosphate homeostasisMarta Christov, Shany Koren, Quan Yuan, et al.
Nature|August 13, 2015
PIK3CA(H1047R) induces multipotency and multi-lineage mammary tumoursShany Koren, Linsey Reavie, Joana Pinto Couto, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 17, 2017
Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2βMieke Raap, Malte Gronewold, Henriette Christgen, et al.
Nature|January 10, 2017
The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERαAdrian Britschgi, Stephan Duss, Sungeun Kim, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Cell|November 23, 2015
Breast Tumor Heterogeneity: Source of Fitness, Hurdle for TherapyShany Koren, Mohamed Bentires-Alj
The FEBS Journal|February 7, 2013
Mouse models of PIK3CA mutations: one mutation initiates heterogeneous mammary tumorsShany Koren, Mohamed Bentires-Alj
Cancer Cell|May 10, 2017
Tackling Resistance to PI3K Inhibition by Targeting the EpigenomeShany Koren, Mohamed Bentires-Alj
Nature Reviews. Genetics|November 21, 2023
Interrogating epigenetic mechanisms with chemically customized chromatinNir Hananya, Shany Koren, Tom W Muir
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2023
A genetically encoded photoproximity labeling approach for mapping protein territoriesNir Hananya, Xuanjia Ye, Shany Koren, et al.
Endocrinology|March 24, 2011
Genetic ablation of sfrp4 in mice does not affect serum phosphate homeostasisMarta Christov, Shany Koren, Quan Yuan, et al.
Nature|August 13, 2015
PIK3CA(H1047R) induces multipotency and multi-lineage mammary tumoursShany Koren, Linsey Reavie, Joana Pinto Couto, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 17, 2017
Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2βMieke Raap, Malte Gronewold, Henriette Christgen, et al.
Nature|January 10, 2017
The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERαAdrian Britschgi, Stephan Duss, Sungeun Kim, et al.
Pageof 1